InvestorsHub Logo
Followers 26
Posts 5707
Boards Moderated 0
Alias Born 10/01/2011

Re: None

Wednesday, 10/31/2018 10:44:03 AM

Wednesday, October 31, 2018 10:44:03 AM

Post# of 39183
The 3Q'2018 10-Q (8/31/18) has been filed per website on 10/30/18. Basically, little change in management's discussion of operations and the financial position of the company. In summary, the sales of Emesyl and Emesyl Plus are not in sufficient volume to result in a profit. Notwithstanding the sale of the products in several venues, there appears to be insufficient advertising and product exposure in the market.